Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-03
2005-05-03
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S097000
Reexamination Certificate
active
06887884
ABSTRACT:
Compounds of the formulaand their pharmaceutically acceptable salts, wherein R1, R2, and R3are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders.
REFERENCES:
patent: 3471503 (1969-10-01), Carson
patent: 0 955 301 (1999-11-01), None
patent: 1 078 637 (2001-02-01), None
patent: WO 9955680 (1999-11-01), None
patent: WO 0044755 (2000-08-01), None
patent: WO 0045846 (2000-08-01), None
Mazzocchi et al., Synthesis and Pharmacological Activity of 2,3,4,5-Tetrahydro-1,5-methano-1H-benzazepines, Journal of Medicinal Chemistry, vol. 22, No. 4, pp. 455-457, 1979.
Brooks Paige Roanne Palmer
Coe Jotham Wadsworth
Coleman Brenda
Joran A. David
Ling Lorraine B.
Pfizer Inc
Richardson Peter C.
LandOfFree
Aryl fused azapolycyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl fused azapolycyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl fused azapolycyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3452402